Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Gabapentin and Median Nerve Neural Mobilization Versus Control in the Treatment of Carpal Tunnel Syndrome

NCT04285281 is registered in ClinicalTrials.gov with Universidad Europea de Madrid as lead sponsor.

NCT NCT04285281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04285281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Gabapentin and Median Nerve Neural Mobilization Versus Control in the Treatment of Carpal Tunnel Syndrome
Lead sponsor
Universidad Europea de Madrid
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2020
Completion date
August 10, 2020
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carpal tunnel syndrome